NEW MJ NEWS

Verano Announces First Quarter 2024 Financial Results

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the first quarter ended March 31, 2024, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

First Quarter 2024 Financial Highlights

For the Three Months Ended,

($ in thousands)

March 31, 2024

December 31, 2023

March 31, 2023

Revenues, net of Discounts

$

221,306

$

237,189

$

227,060

Gross Profit

112,960

117,610

109,185

Income (Loss) from Operations

22,671

(19,716

)

33,782

Net Loss Attributable to Verano Holdings Corp. & Subsidiaries

(4,822

)

(77,208

)

(9,237

)

Adjusted EBITDA1

66,547

73,376

70,635

First Quarter 2024 Financial Highlights

Revenue of $221 million, a decrease of 3% year-over-year, and a decrease of 7% versus the prior quarter, exceeding Company guidance.

Gross profit of $113 million or 51% of revenue.

SG&A expense of $90 million or 41% of revenue.

Net loss of $(5) million or (2)% of revenue.

Adjusted EBITDA1 of $67 million or 30% of revenue.

Net cash provided by operating activities of $31 million.

Free Cash Flow2 of $21 million.

Capital expenditures of $10 million.

Management Commentary
“I am tremendously proud of the strong foundation we’ve built in the first quarter, which positions Verano to capitalize on what may be one of the most transformative years for legal cannabis in our nation’s history,” said George Archos, Verano founder and Chief Executive Officer. “While we’ve never built our business based on legislative assumptions, we have tremendous upside across all of our markets to take advantage of the massive potential catalysts that lie ahead in 2024. With adult use imminent in Ohio, confirmed on the November ballot in Florida, and on the horizon in Pennsylvania, we have significant opportunities in these core Verano markets where we currently operate nearly 100 retail dispensaries alone. If fully approved, layering on DEA rescheduling would have also enabled us to save an estimated $80 million in tax payments in 2023, allowing us to reinvest back into the business, and take swift action towards listing on a U.S. exchange if permitted.”

Archos concluded: “With the growing strength of our wholesale business in key markets, disruptive innovation demonstrated by our launch of the nation’s first dispensary membership model in Cabbage Club, state and federal catalysts on the horizon, and our team’s proven operational experience and agility converting medical to adult use markets throughout our history, I remain confident and excited in what Verano can achieve in 2024 and beyond.”

First Quarter 2024 Financial Overview

Revenue for the first quarter 2024 was $221 million, down 3% from $227 million for the first quarter 2023, and down 7% from $237 million for the fourth quarter 2023. The decrease in revenue for the first quarter 2024 compared to the first quarter 2023 was driven primarily by expected declines in New Jersey retail as dispensaries continue to open across the state, which was partially offset by stronger-than-expected performance from the wholesale segment.

Gross profit for the first quarter 2024 was $113 million or 51% of revenue, up from $109 million or 48% of revenue for the first quarter 2023, and down from $118 million or 50% of revenue for the fourth quarter 2023. The increase in gross profit for the first quarter 2024 compared to the first quarter 2023 was driven primarily by higher third-party wholesale sales.

SG&A expense for the first quarter 2024 was $90 million or 41% of revenue, up from $75 million or 33% of revenue for the first quarter 2023, and up from $86 million or 36% of revenue for the fourth quarter 2023. The increase in SG&A expense for the first quarter 2024 compared to the first quarter 2023 was driven primarily by new dispensary openings in addition to investments in people, processes, and technology.

Net loss for the first quarter 2024 was $(5) million, or (2)% of revenue, versus $(9) million, or (4)% of revenue in the first quarter 2023. The decrease in net loss for the first quarter 2024 compared to the first quarter 2023 was due to a decrease in provision for income tax expense versus the prior year period.

Adjusted EBITDA1 for the first quarter 2024 was $67 million or 30% of revenue.

Net cash provided by operating activities for the first quarter 2024 was $31 million, up from $17 million for the first quarter 2023.

Capital expenditures for the first quarter 2024 were $10 million, up from $9 million for the first quarter 2023.

Free cash flow2 for the first quarter 2024 was $21 million, up from $8 million for the first quarter 2023.

2024 Guidance
The Company issued flat to low single-digit revenue growth guidance for the second quarter 2024.

First Quarter 2024 Operational Highlights

Expanded the Company’s retail footprint by opening the following new dispensaries:

MÜV™ Yulee, raising the Company’s total Florida footprint to 74 statewide locations;

and in Pennsylvania, Zen Leaf™ Abington, Verano’s largest dispensary nationwide by square footage in a prime new location, along with Zen Leaf Norristown, the Company’s 18th affiliated Pennsylvania dispensary.

Launched Cabbage Club™, the first nationwide proprietary multi-state cannabis membership club, offering consumers the opportunity to join to unlock exclusive benefits, in two of the nation’s largest cannabis markets – Illinois and New Jersey – with plans to further scale across the Company’s footprint in 2024.

Subsequent Operational Highlights

Joined the Smart and Safe Florida coalition of industry stakeholders advocating for the passage of the Amendment 3 adult use ballot initiative this November.

Strengthened Connecticut retail footprint with the opening of Zen Leaf Naugatuck, the Company’s third social equity joint venture location and fifth dispensary statewide.

Current operations span 13 states, comprised of 139 dispensaries and 14 production facilities with more than one million square feet of cultivation capacity.

Balance Sheet and Liquidity

As of March 31, 2024, the Company’s current assets were $419 million, including cash and cash equivalents of $194 million. The Company had working capital of $4 million and total debt, net of issuance costs, of $445 million.

Subsequent to the quarter end, the Company prepaid $50 million of its senior credit facility, decreasing the principal balance to $300 million, and retaining optionality to further decrease the principal balance in the future.

The Company’s total Class A subordinate voting shares outstanding was 344,163,149 as of March 31, 2024.

Conference Call and Webcast

A conference call and webcast with analysts and investors is scheduled for May 8, 2024 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and participant questions.

Investors and participants can register in advance for the call by visiting: https://registrations.events/direct/Q4I4391535

After registering, instructions will be shared on how to join the call for those who wish to dial in.

On May 8, 2024, the live webcast can be accessed via the following link: https://events.q4inc.com/attendee/137566685

The live and archived webcast will be available on the Events and Presentations page of the Company’s investor relations website at investors.verano.com.

_________________________
1Adjusted EBITDA is a non-U.S. GAAP financial measure. It is derived from EBITDA, another non-U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The most directly comparable U.S. GAAP financial measure to adjusted EBITDA is net income (loss). The reconciliation of adjusted EBITDA to U.S. GAAP net income (loss) is set forth below in the tables included in this news release.
2 Free cash flow is a non-U.S. GAAP financial measure. It is derived from U.S. GAAP net cash provided by operating activities, which is also its most directly comparable U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The reconciliation of free cash flow to U.S. GAAP net cash provided by operating activities is set forth below in the tables included in this news release.

Non-U.S. GAAP Financial Measures

Verano uses non-U.S. GAAP financial information to evaluate the performance of the Company. The terms “EBIT,” “EBITDA,” “adjusted EBITDA,” and “free cash flow” do not have any standardized meaning prescribed within U.S. GAAP and therefore may not be comparable to similar measures presented by other companies. Accordingly, this non-U.S. GAAP financial information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with U.S. GAAP.

The Company calculates EBIT as net income (loss) before interest expense and income tax expense; EBITDA as net income (loss) before interest expense, income tax expense, depreciation, and amortization; adjusted EBITDA as net income (loss) plus net interest expense, income tax expense, depreciation and amortization and also excludes certain one-time extraordinary items; and free cash flow as net cash provided by operating activities less capital expenditures. The calculations of the non-U.S. GAAP financial measures used in this news release and the reconciliations to the most comparable U.S. GAAP financial numbers are included in the tables below.

Management believes that this non-U.S. GAAP financial information is useful as a supplement to comparable U.S. GAAP financial information because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP information to supplement their GAAP results. Management reviews these non-U.S. GAAP financial measures on a regular basis and uses them, together with financial measures included in the Company’s financial statements, to evaluate and manage the performance of the Company’s operations. These measures should be evaluated only in conjunction with the comparable U.S. GAAP financial numbers reported by the Company.

About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners, including Cabbage Club™, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, (the) Essence™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at Verano.com.

Contacts:
Investors
Verano
Julianna Paterra, CFA
VP, Investor Relations
julianna.paterra@verano.com

Media
Verano
Steve Mazeika
VP, Communications
steve.mazeika@verano.com
312-348-4430

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2023 and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at www.sec.gov.The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

Financial Information Tables

The following tables include select financial results and the reconciliations of the non-U.S. GAAP financial measures to the respective most directly comparable U.S. GAAP financial measures for the presented periods.

VERANO HOLDINGS CORP.
Highlights from Unaudited Interim Condensed Consolidated Statements of Operations
($ in Thousands)

For the Three Months Ended,

March 31, 2024

December 31, 2023

March 31, 2023

Revenues, net of Discounts

$

221,306

$

237,189

$

227,060

Cost of Goods Sold, net

108,346

119,579

117,875

Gross Profit

112,960

117,610

109,185

Gross Profit %

51

%

50

%

48

%

Operating Expenses

Selling, General and Administrative

90,289

85,709

75,243

Loss on Impairment of Intangibles – Goodwill

37,931

Loss on Impairment of Intangibles – License & Fixed Assets

13,686

Total Operating Expenses

90,289

137,326

75,243

Loss from Investments in Associates

(160

)

Income (Loss) from Operations

22,671

(19,716

)

33,782

Other Income (Expense), net:

Gain (Loss) on Disposal of Property, Plant and Equipment

(143

)

(568

)

67

Loss on Debt Extinguishment

(663

)

Interest Expense, net

(15,114

)

(14,708

)

(15,906

)

Other Income (Expense), net

(759

)

2,056

1,803

Total Other Income (Expense), Net

(16,016

)

(13,220

)

(14,699

)

Income (Loss) Before Provision for Income Taxes and Non-Controlling Interest

6,655

(32,936

)

19,083

Provision for Income Expense

(11,477

)

(44,350

)

(28,320

)

Net Loss Attributable To Non-Controlling Interest

(78

)

Net Loss Attributable to Verano Holdings Corp. & Subsidiaries

(4,822

)

(77,208

)

(9,237

)

VERANO HOLDINGS CORP.
Highlights from Condensed Consolidated Balance Sheets
($ in Thousands)

March 31, 2024

December 31, 2023

(Unaudited)

Cash and Cash Equivalents

$

193,799

$

174,760

Other Current Assets

224,980

219,436

Property and Equipment, Net

499,142

501,304

Intangible Assets, Net

1,063,359

1,086,146

Goodwill

231,291

231,291

Other Long-Term Assets

102,449

105,808

Total Assets

$

2,315,020

$

2,318,745

Total Current Liabilities

$

414,975

$

412,188

Total Long-Term Liabilities

661,129

666,477

Total Shareholders’ Equity

1,238,916

1,240,080

Non-Controlling Interest

Total Liabilities and Shareholders’ Equity

$

2,315,020

$

2,318,745

VERANO HOLDINGS CORP.
Segmented Revenues, net of Discounts, By State (Unaudited)

For the Three Months Ended,

Net Retail Revenues, net of Discounts

March 31, 2024

December 31, 2023

($ in thousands)

Florida

$

50,317

$

59,695

Illinois

27,345

29,299

New Jersey

22,782

26,337

Arizona

14,973

15,626

Pennsylvania

12,066

12,587

Maryland

10,253

10,875

Connecticut

10,023

8,862

Nevada

7,166

7,097

Ohio

5,462

5,868

Massachusetts

2,906

2,984

West Virginia

1,715

1,625

Other

3,580

4,264

Total Net Retail Revenues, net of Discounts

$

168,588

$

185,119

For the Three Months Ended,

March 31, 2024

December 31, 2023

Wholesale Revenues, net of Discounts

Gross

Net1

Gross

Net1

($ in thousands)

New Jersey

$

24,164

$

17,698

$

24,049

$

15,511

Illinois

18,204

11,018

19,227

11,027

Connecticut

12,853

8,766

14,204

10,342

Maryland

8,005

4,830

8,444

5,384

Pennsylvania

6,677

3,631

7,476

3,781

Arizona

6,684

2,365

7,084

2,575

Nevada

3,250

1,158

2,924

845

Ohio

2,179

1,160

1,857

914

Massachusetts

1,966

1,178

1,640

809

West Virginia

1,924

914

1,665

882

Total Wholesale Revenues, net of Discounts

$

85,906

$

52,718

$

88,570

$

52,070

1Net of intercompany eliminations

VERANO HOLDINGS CORP.
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow (Non-U.S. GAAP)

For the Three Months Ended,

March 31, 2024

March 31, 2023

($ in thousands)

(Unaudited)

(Unaudited)

Net Cash Provided by Operating Activities

$

31,041

$

16,862

Purchase of property, plant, and equipment

(9,699

)

(8,555

)

Free Cash Flow

$

21,342

$

8,307

VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBITDA (Non-U.S. GAAP)

For the Three Months Ended,

March 31, 2024

December 31, 2023

March 31, 2023

($ in thousands)

(Unaudited)

(Unaudited)

(Unaudited)

Net Loss Attributable to Verano Holdings Corp. & Subsidiaries

$

(4,822

)

$

(77,208

)

$

(9,237

)

Interest Expense, net

15,114

14,708

15,906

Income Tax Expense

11,477

44,350

28,320

Depreciation and Amortization – COGS

18,643

18,417

18,522

Depreciation and Amortization – SG&A

16,909

17,157

16,534

Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA)

$

57,321

$

17,424

$

70,045

VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBIT (Non-U.S. GAAP) and Adjusted EBITDA (Non-U.S. GAAP)

For the Three Months Ended,

March 31, 2024

December 31, 2023

March 31, 2023

($ in thousands)

(Unaudited)

(Unaudited)

(Unaudited)

Net Loss Attributable to Verano Holdings Corp. & Subsidiaries

$

(4,822

)

$

(77,208

)

$

(9,237

)

Interest Expense, Net

15,114

14,708

15,906

Income Tax Expense

11,477

44,350

28,320

Earnings Before Interest, Taxes (EBIT)

$

21,769

$

(18,150

)

$

34,989

COGS Add-backs:

Depreciation and Amortization – COGS

18,643

18,417

18,522

Acquisition, Transaction and Other Non-operating Costs

Employee Stock Compensation

474

970

586

SG&A Add-backs:

Depreciation and Amortization – SG&A

16,909

17,157

16,534

Acquisition, Transaction and Other Non-operating Costs

3,476

595

494

Employee Stock Compensation

3,454

3,281

(42

)

Impairment – Goodwill & License

51,617

Acquisition Adjustments and Other Income (Expense), net

1,822

(511

)

(448

)

Adjusted EBITDA

$

66,547

$

73,376

$

70,635

Net Loss Margin

(2

)%

(33

)%

(4

)%

Adjusted EBITDA Margin

30

%

31

%

31

%


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CBIS Partnership Opportunities with Harvard Medical School

Harvard Director of Global Health Catalyst at the World-Renowned Dana Farber/Harvard Cancer…

$HEMP Announces Hemp Blue, Inc. Nearing End Successful Kickstarter Campaign

Two Days Left to Buy Hemp Jeans by Hemp Blue LAS VEGAS,…

MariMed Inc. (MRMD) Closes $58.7 Million Debt Refinancing

MariMed Closes $58.7 Million Debt Refinancing MariMed Inc. (“MariMed” or the “Company”)…

Grow Capital, Inc (GRWC) Names Award-Winning Businessman and Author Terry Kennedy as Chief Executive Officer

Grow Capital, Inc Names Award-Winning Businessman and Author Terry Kennedy as Chief…